| Total population (n = 408) | NFG (n = 253) | IFG- ADA (n = 118) | NDM(n = 37) | P-Value | Statistics b |
---|---|---|---|---|---|---|
Continuous variables, mean (SD) | ||||||
 Age (years) | 60.6 (10.5) | 60.0 (10.9) | 61.3 (10.2) | 62.8 (8.7) | 0.22 | 1.51 |
 BMI (kg/m2) | 28.2 (4.7) | 27.6 (4.6) | 29.0 (4.8) | 29.2 (4.8) | 0.009 | 4.82 |
 WC (cm) | 97.1 (10.5) | 95.6 (10.6) | 99.2 (9.8) | 100.7 (9.6) | 0.001 | 7.54 |
 SBP (mmHg) | 130.7 (21.2) | 128. 4 (20.3) | 132.8 (20.7) | 139.2 (25.6) | 0.006 | 5.22 |
 DBP (mmHg) | 78.4 (11.8) | 78.2(12.2) | 78.1 (11.4) | 80.2 (9.6) | 0.62 | 0.48 |
 HR (beats/minute) | 76.7 (11.9) | 75.7(12.0) | 78.3 (12.1) | 78.7 (9.9) | 0.08 | 2.49 |
 FPG (mmol/L) | 5.6 (1.4) | 5.0(0.4) | 6.1 (0.4) | 9.1 (2.1) |  < 0.001 | 555.01 |
 2 h-PCPG (mmol/L) | 8.2 (4.3) | 6.4(1.8) | 8.9 (2.6) | 18.2 (5.8) |  < 0.001 | 323.8 |
 TC (mmol/L) | 5.4 (1.1) | 5.3 (1.1) | 5.4(1.0) | 5.8 (1.4) | 0.04 | 3.25 |
 HDL-C (mmol/L) | 0.98(0.2) | 0.98(0.2) | 0.97(0.3) | 0.94 (0.3) | 0.69 | 0.37 |
 Triglycerides (mmol/L) a | 1.85(1.24) | 1.8(1.2) | 1.8(1.3) | 2.4 (1.3) | 0.04 | 4.23 |
Categorical variables, n (%) | ||||||
 Gender (men) | 238(58.3) | 150(59.3) | 64(54.2) | 24(64.9) | 0.47 | 1.56 |
 Family history of CVD | 62(15.2) | 39(15.4) | 19(16.1) | 4(10.8) | 0.79 | 0.51 |
 Current smoking | 69(16.9) | 42(16.6) | 20(16.9) | 7(18.9) | 0.94 | 0.12 |
 Low physical activity | 174(42.6) | 114(45.1) | 53(44.9) | 7(18.9) | 0.007 | 9.37 |
 Hypertension | 218(53.4) | 131(51.8) | 66(55.9) | 21(56.8) | 0.69 | 0.74 |
 Hypercholesterolemia | 245(60.0) | 149(58.9) | 73(61.9) | 23(62.2) | 0.86 | 0.37 |
Medications | ||||||
 Anti-hypertensive medication | 133(32.6) | 83(32.8) | 37(31.4) | 13(35.1) | 0.88 | 0.20 |
 Lipid-lowering medication | 45(11.0) | 27(10.7) | 13(11.0) | 5(13.5) | 0.83 | 0.27 |
 Aspirin use | 198(48.5) | 129(51.0) | 49(41.5) | 20(54.1) | 0.17 | 3.38 |